These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 8433041

  • 1. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE, Johnson RJ, Simpson J, Chenoweth DE, Borgia J.
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [Abstract] [Full Text] [Related]

  • 2. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA, Woffindin C, Cox PJ, Goldfinch M, Roberts SJ.
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D.
    Acta Med Croatica; 2004 Oct; 58(1):31-6. PubMed ID: 15125391
    [Abstract] [Full Text] [Related]

  • 4. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G.
    Blood Purif; 2007 Oct; 25(5-6):432-40. PubMed ID: 17957097
    [Abstract] [Full Text] [Related]

  • 5. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE, Boberg U, Jacobson SH, Kjellstrand C, Ljungberg B, Skröder R.
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [Abstract] [Full Text] [Related]

  • 6. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A, Szepietowski T.
    Polim Med; 1992 Nov; 22(1-2):59-72. PubMed ID: 1461837
    [Abstract] [Full Text] [Related]

  • 7. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
    Grooteman MP, Nubé MJ, van Limbeek J, van Houte AJ, Daha MR, van Geelen JA.
    ASAIO J; 1995 Nov; 41(2):215-20. PubMed ID: 7640431
    [Abstract] [Full Text] [Related]

  • 8. Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.
    Schaefer RM, Rauterberg EW, Deppisch R, Vienken J.
    Miner Electrolyte Metab; 1990 Nov; 16(1):73-6. PubMed ID: 2325595
    [Abstract] [Full Text] [Related]

  • 9. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels.
    Varela MP, Kimmel PL, Phillips TM, Mishkin GJ, Lew SQ, Bosch JP.
    Blood Purif; 2001 Nov; 19(4):370-9. PubMed ID: 11574733
    [Abstract] [Full Text] [Related]

  • 10. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
    Krieter DH, Lemke HD, Wanner C.
    Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
    [Abstract] [Full Text] [Related]

  • 11. Polymorphonuclear oxygen free radical production and complement activation induced by dialysis membranes as assayed in an experimental model.
    Cappelli G, Lucchi L, Bonucchi D, Cenci AM, Montagnani G, De Palma M, Lusvarghi E.
    Blood Purif; 1989 Jul; 7(6):293-300. PubMed ID: 2611000
    [Abstract] [Full Text] [Related]

  • 12. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K, Krouzzecký A, Polanská K, Mares J, Tomsů M, Bowry SK, Vienken J.
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [Abstract] [Full Text] [Related]

  • 13. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P, Ortiz M, Ortega O, Rodríguez I, Seijas V, Carreño A, Oliet A, Vigil A.
    Nefrologia; 2007 Apr; 27(1):46-52. PubMed ID: 17402879
    [Abstract] [Full Text] [Related]

  • 14. Physiologic approach to dialysis-induced hypoxemia. Effects of dialyzer material and dialysate composition.
    Igarashi H, Kioi S, Gejyo F, Arakawa M.
    Nephron; 1985 Apr; 41(1):62-9. PubMed ID: 3929152
    [Abstract] [Full Text] [Related]

  • 15. Research on dialyzers with improved biocompatibility.
    van der Steen A.
    Clin Nephrol; 1986 Apr; 26 Suppl 1():S39-42. PubMed ID: 3829466
    [Abstract] [Full Text] [Related]

  • 16. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M, Lietaer N, Lambert P, Thayse C, Vanherweghem JL.
    Life Support Syst; 1987 Apr; 5(4):317-22. PubMed ID: 3501504
    [Abstract] [Full Text] [Related]

  • 17. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
    Lonnemann G, Koch KM, Shaldon S, Dinarello CA.
    J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
    [Abstract] [Full Text] [Related]

  • 18. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
    de Vinuesa SG, Resano M, Luño J, Gonzalez C, Barril G, Junco E, Valderrabano F.
    Proc Eur Dial Transplant Assoc; 1983 Jul; 19():159-67. PubMed ID: 6878230
    [Abstract] [Full Text] [Related]

  • 19. Is the dialysate fluid source of complement activating factors?
    Minetti L, Broggi ML, Civati G, Guastoni C, Teatini U.
    Trans Am Soc Artif Intern Organs; 1985 Jul; 31():673-7. PubMed ID: 3879782
    [Abstract] [Full Text] [Related]

  • 20. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E, Moczulski D, Grzeszczak W, Gosek K, Augustyn M, Staszewicz P.
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.